

| Revenue | Less than $1 million See Exact Annual Revenue |
|---|---|
| Employees | 1 - 10Exact Company Size |
| Primary Industry | 339112 Surgical & Medical Instrument Manufacturing |
| Additional NAICS Codes | 339113 Surgical Appliance & Supplies Manufacturing 4543 Direct Selling Establishments |
| Address | 8023 Vantage Dr Ste 1000 San Antonio, TX 78230 |
| C-Nova Coatings | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | Less than $1 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| C-Nova Coatings P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Date | Investors | Percent Raised | Target Size |
|---|---|---|---|
| February 15, 2011 | 81 | 100% | $21 MM |
| Complete list of funding rounds and total amounts in the Company Report | |||
| Trademark | Date |
|---|---|
| EMBOZENE MICROSPHERES Coated medical devices for embolization, namely, embolic microspheres for embolization and syringes; Coated medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Coated medical devices for embolization, namely, embolic devices in the form of particles to slow or block blood flow for mediating devascularizations; Coated medical devices for embolization, namely, embolic devices in the form of particles to block blood flow throughout the vasculature system of mammals; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Coated medical devices for embolization, namely, embolic devices in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat vascular conditions | 05/01/2014 |
| COBRA PZF stent and stent delivery catheter; stent delivery system | 04/25/2014 |
| ONCOZENE Medical products, namely, embolic microspheres for use in endovascular therapy, for treatment of hypervascularized tumors and to control and prevent abnormal bleeding; Medical products, namely, embolic microspheres for embolization in the form of particles; Medical products, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical products, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical products, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical products, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical products, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical products, namely, embolic microspheres in the form of embolic particle implants; Medical products, namely, embolic microspheres for treating vascular anomalies of the body | 03/11/2013 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| EMBECTA | Parsippany, NJ | 100 |
| STRUCTURE MEDICAL | Mooresville, NC | 34 |
| AUTOCAM MEDICAL DEVICES | Kentwood, MI | 30 |
| SCHARNBERG HOLDING | Des Moines, IA | 26 |
| SPECIALTY SURGICAL INSTRUMENTATION | Antioch, TN | 24 |
| MIDWEST INTERVENTIONAL SYSTEMS | Maple Grove, MN | 19 |
| VITA NEEDLE | Needham, MA | 17 |
| PYLANT MEDICAL | Grapevine, TX | 17 |
| MEDTEC | Orange City, IA | 16 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| KINETIC CONCEPTS | San Antonio, TX | 100 |
| BULOW BIOTECH PROSTHETICS | San Antonio, TX | 8 |
| SA SCIENTIFIC | San Antonio, TX | 3 |
| FOOTPRINT MEDICAL | San Antonio, TX | 2 |
| SENO MEDICAL INSTRUMENTS | San Antonio, TX | 2 |
| NEU LIMBS | San Antonio, TX | 1 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |